Holen Sie sich die Stockscreener-App
2.52
2.70%
-0.07
Handel nachbörslich:
2.53
0.010
+0.40%
Schlusskurs vom Vortag:
$2.59
Offen:
$2.61
24-Stunden-Volumen:
1.28M
Relative Volume:
0.70
Marktkapitalisierung:
$362.82M
Einnahmen:
$288.95M
Nettoeinkommen (Verlust:
$-119.03M
KGV:
-2.7984
EPS:
-0.9005
Netto-Cashflow:
$60.67M
1W Leistung:
-8.70%
1M Leistung:
+16.67%
6M Leistung:
-44.86%
1J Leistung:
-72.64%
1-Tages-Spanne:
$2.48
$2.68
1-Wochen-Bereich:
$2.48
$2.93
52-Wochen-Spanne:
$1.665
$10.03
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Firmenname
Maravai Lifesciences Holdings Inc
Sektor
Branche
Telefon
(858) 546-0004
Adresse
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Vergleichen Sie MRVI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
2.52 | 397.37M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.55 | 123.00B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.93 | 59.66B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.81 | 41.84B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.92 | 33.98B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
279.16 | 27.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | Eingeleitet | Guggenheim | Neutral |
| 2024-12-05 | Herabstufung | Goldman | Neutral → Sell |
| 2024-11-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-08 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | Eingeleitet | Craig Hallum | Buy |
| 2023-12-12 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-08-08 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | Herabstufung | Goldman | Buy → Neutral |
| 2023-01-05 | Herabstufung | UBS | Buy → Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-11-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Eingeleitet | BofA Securities | Buy |
| 2020-12-15 | Eingeleitet | Credit Suisse | Outperform |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-15 | Eingeleitet | Jefferies | Buy |
| 2020-12-15 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-12-15 | Eingeleitet | Stifel | Buy |
| 2020-12-15 | Eingeleitet | William Blair | Outperform |
| 2020-12-14 | Eingeleitet | UBS | Buy |
Alle ansehen
Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten
Why Maravai LifeSciences Holdings Inc. stock attracts strong analyst attention5x Profit Potential - beatles.ru
What makes Maravai LifeSciences Holdings Inc. stock price move sharplyHigh Potential Safe Trades - Newser
How Maravai LifeSciences Holdings Inc. stock performs during market volatilityProtected Capital Trading Plan - Newser
MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out - ACCESS Newswire
MARAVAI LIFESCIENCES INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc.MRVI - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Traders Purchase High Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - Defense World
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Rating of “Hold” by Brokerages - Defense World
Johnson Fistel, PLLP Investigates Quantum Computing, AppLovin, Skyworks Solutions, and Maravai LifeSciences - GlobeNewswire
Maravai LifeSciences Holdings, Inc.(NasdaqGS:MRVI) dropped from Russell 2000 Growth Index - MarketScreener
Maravai LifeSciences (MRVI) Undergoes Leadership Overhaul Amid Transition - Insider Monkey
Maravai LifeSciences appoints Raj Asarpota as new CFO By Investing.com - Investing.com Nigeria
Maravai LifeSciences (MRVI) Appoints New CFO Amid Leadership Transition | MRVI Stock News - GuruFocus
Maravai Shareholder Sues Over Accounting, Impairment Realization - Bloomberg Law News
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
SG Americas Securities LLC Acquires 662,861 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Maravai LifeSciences appoints Bernd Brust as CEO - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out - ACCESS Newswire
Investors Purchase Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - Defense World
MRVI Set to Host Global Bioproduction Conference Call | MRVI Stock News - GuruFocus
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of “Hold” by Analysts - Defense World
Maravai LifeSciences names Bernd Brust as new CEO By Investing.com - Investing.com South Africa
Maravai Lifesciences Appoints Bernd Brust As CEO & Member Of Its Board Of Directors - MarketScreener
Maravai LifeSciences Names Bernd Brust as CEO - marketscreener.com
Maravai LifeSciences (MRVI) Names Bernd Brust as New CEO | MRVI Stock News - GuruFocus
Maravai Lifesciences Appoints Bernd Brust as New CEO - TipRanks
Maravai LifeSciences Appoints Bernd Brust as Chief Executive Off - GuruFocus
Maravai LifeSciences names Bernd Brust as new CEO - Investing.com Australia
Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors | MRVI Stock News - GuruFocus
Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors - GlobeNewswire
Life Sciences Leader Maravai Taps Industry Veteran Bernd Brust as CEO to Accelerate Growth in Genomic Medicine - Stock Titan
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Sold by Two Sigma Investments LP - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.37 Million Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect - ACCESS Newswire
Maravai LifeSciences (NASDAQ:MRVI) Stock Price Up 8.5% – Time to Buy? - Defense World
Jane Street Group LLC Cuts Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out - ACCESS Newswire
Quantoom Biosciences and TriLink BioTechnologies Sign a Supply and License Agreement - Insider Monkey
TriLink and Quantoom partner to expand global vaccine access By Investing.com - Investing.com South Africa
MRVI: TriLink BioTechnologies Partners with Quantoom for Enhanced mRNA Production | MRVI Stock News - GuruFocus
TriLink and Quantoom partner to expand global vaccine access - Investing.com Australia
Maravai's TriLink, Quantoom Sign License, Supply Agreement - marketscreener.com
Leading COVID-19 Vaccine Technology CleanCap Expands Global Access Through Quantoom Partnership - Stock Titan
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stock Holdings Cut by Bank of America Corp DE - Defense World
ProShare Advisors LLC Raises Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Finanzdaten der Maravai Lifesciences Holdings Inc-Aktie (MRVI)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.40%
2.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):